Short‐Term Efficacy of Different First‐Line Chemotherapy Regimens for Advanced Non‐Small Cell Lung Cancer: A Network Meta‐Analysis

Short‐Term Efficacy of Different First‐Line Chemotherapy Regimens for Advanced Non‐Small Cell Lung Cancer: A Network Meta‐Analysis

This study intends to compare short‐term efficacy of 12 chemotherapy regimens in treatment of advanced non‐small cell lung cancer (NSCLC) by a network meta‐analysis (NMA). PubMed, Cochrane Library, and Embase were searched from the inception of each database to June 2018. Randomized controlled trial...

Full description

Bibliographic Details
Main Authors:	Bei‐Bei Zhang, Weibo Zhu, Jun Tao, Yun Li, Chuan‐Chong Du, Yun‐Xia Chen, Yan‐Dong Liu
Format:	Article
Language:	English
Published:	Wiley 2020-05-01
Series:	Clinical and Translational Science
Online Access:	https://doi.org/10.1111/cts.12744

Similar Items

Response to first line chemotherapy regimen is associated with efficacy of nivolumab in non-small-cell lung cancer
by: Courèche-Guillaume Kaderbhai, et al.
Published: (2017-09-01)

The Most Efficacious Induction Chemotherapy Regimen for Locoregionally Advanced Nasopharyngeal Carcinoma: A Network Meta-Analysis
by: Horace Cheuk-Wai Choi, et al.
Published: (2021-02-01)

Efficacy and Safety of Chemotherapy Regimens in Advanced or Metastatic Bladder and Urothelial Carcinomas: An Updated Network Meta-Analysis
by: Hong-Chen Qu, et al.
Published: (2020-01-01)

The efficacy of combining antiangiogenic agents with chemotherapy for patients with advanced non-small cell lung cancer who failed first-line chemotherapy: a systematic review and meta-analysis.
by: Jin Sheng, et al.
Published: (2015-01-01)

Combination of EGFR-TKIs and chemotherapy as first-line therapy for advanced NSCLC: a meta-analysis.
by: Pu-Yun OuYang, et al.
Published: (2013-01-01)

Network Meta-Analysis of Efficacy and Safety of Chemotherapy and Target Therapy in the First-Line Setting of Advanced Pancreatic Cancer
by: Kun-I Lin, et al.
Published: (2019-11-01)

Efficacy of first-line oxaliplatin-based chemotherapy regimens depending on the KRAS mutation status
by: M. Yu. Fedyanin, et al.
Published: (2018-05-01)

The Influence of KDR Genetic Variation on the Efficacy and Safety of Patients With Advanced NSCLC Receiving First-Line Bevacizumab Plus Chemotherapy Regimen
by: Nan Geng MD, et al.
Published: (2021-05-01)

Atezolizumab Monotherapy or Plus Chemotherapy in First-Line Treatment for Advanced Non-Small Cell Lung Cancer Patients: A Meta-Analysis
by: Dan-Ni Li, et al.
Published: (2021-06-01)

The Efficacy of Different Chemotherapy Regimens for Advanced Biliary Tract Cancer: A Systematic Review and Network Meta-Analysis
by: Yan Li, et al.
Published: (2019-05-01)

Efficacy of pemetrexed plus platinum doublet chemotherapy as first-line treatment for advanced nonsquamous non-small-cell-lung cancer: a systematic review and meta-analysis
by: Xiao HQ, et al.
Published: (2016-03-01)

First-line chemotherapy regimens for locally advanced and metastatic pancreatic adenocarcinoma: a Bayesian analysis
by: Zhang S, et al.
Published: (2018-11-01)

Association between the ALK Gene Status and the Efficacy of First-line  Pemetrexed Chemotherapy in Patients with Advanced Lung Adenocarcinoma
by: Mengge CHEN, et al.
Published: (2017-11-01)

Efficacy and Safety of First-Line Chemotherapies for Patients With Advanced Biliary Tract Carcinoma: A Systematic Review and Network Meta-Analysis
by: Yanfeng Jiang, et al.
Published: (2021-09-01)

Chemotherapy with or without pemetrexed as second-line regimens for advanced non-small-cell lung cancer patients who have progressed after first-line EGFR TKIs: a systematic review and meta-analysis
by: Li ZH, et al.
Published: (2018-06-01)

Rational application of the first‐line chemotherapy and immune checkpoint inhibitors in advanced nonsmall cell lung cancer: A meta‐analysis
by: Rui Cao, et al.
Published: (2019-09-01)

The Changes of the first-line Chemotherapy on Advanced non-small Cell Lung Cancer
by: Baohui HAN, et al.
Published: (2008-04-01)

Efficacy of First Line Systemic Chemotherapy and Multikinase Inhibitors in Advanced Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis
by: Songporn Oranratnachai, et al.
Published: (2021-03-01)

Intercalated Combination of Chemotherapy and EGFR-TKIs versus Chemotherapy Alone in the First-line Treatment of Advanced Non-small Cell Lung Cancer: A Meta-analysis
by: Chaoyu HONG, et al.
Published: (2016-12-01)

Comparative efficacy and safety for different chemotherapy regimens used concurrently with thoracic radiation for locally advanced non-small cell lung cancer: a systematic review and network meta-analysis
by: Tingting Liu, et al.
Published: (2019-03-01)

The Efficacy and Safety of First-Line Chemotherapy in Patients With Non-small Cell Lung Cancer and Interstitial Lung Disease: A Systematic Review and Meta-Analysis
by: Yanning Wang, et al.
Published: (2020-09-01)

Efficacy and Safety of PD-1/PD-L1 Inhibitor Versus Chemotherapy in First-line Treatment of Advanced Non-small Cell Lung Cancer: A Meta-analysis
by: WEI Yu, et al.
Published: (2019-05-01)

Advance of second-line chemotherapy in advanced non-small cell lung cancer
by: Li ZHANG
Published: (2008-02-01)

Reevaluation of the Efficacy of First Line Regimen for Helicobacter pylori
by: Tariq H, et al.
Published: (2020-01-01)

Effectiveness of EGFR-TKIs versus Chemotherapy as First-line Treatment for Advanced Non-small Cell Lung Cancer: A Meta-analysis
by: Feifei CAO, et al.
Published: (2015-03-01)

First-line treatment of chronic lymphocytic leukemia with three combined chemotherapy regimens
by: Matevž Škerget
Published: (2012-12-01)

Efficacy of EGFR-TKI Plus Chemotherapy or Monotherapy as First-Line Treatment for Advanced EGFR-Mutant Lung Adenocarcinoma Patients With Co-Mutations
by: Zhengyu Yang, et al.
Published: (2021-08-01)

Association between the HER2 Gene Status and the Efficacy of First-line Pemetrexed Combined with Platinum Chemotherapy in Patients with Advanced Lung  Adenocarcinoma
by: Panhua LI, et al.
Published: (2019-03-01)

Association between the Epidermal Growth Receptor Status and the Efficacy of First-line Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer
by: Na QIN, et al.
Published: (2015-03-01)

Efficacy of plasma vascular endothelial growth factor in monitoring first-line chemotherapy in patients with advanced non-small cell lung cancer
by: Mohan Anant, et al.
Published: (2009-12-01)

Impact of Anemia on Chemotherapy Efficacy and Prognosis in Patients with Advanced Non-small Cell Lung Cancer
by: Chong'an XU, et al.
Published: (2010-10-01)

Efficacy of First Line Target Therapy in Patients with Advanced Lung Adenocarcinoma
by: Yn-Fang Lin, et al.
Published: (2017)

Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for first-line treatment in advanced non-small cell lung carcinoma: a systematic review and meta-analysis
by: Yixin Zhou, et al.
Published: (2018-12-01)

Efficacy and Safety of Bevacizumab Combined with Chemotherapy as Second-line or Later-line Treatment in Advanced Nonsquamous Non-small Cell Lung Cancer
by: Xuanxuan ZHENG, et al.
Published: (2018-07-01)

Association between TYMS expression and efficacy of pemetrexed-based chemotherapy in advanced non-small cell lung cancer: a meta-analysis.
by: Ting Wang, et al.
Published: (2013-01-01)

Efficacy and safety of COX-2 inhibitors for advanced non-small-cell lung cancer with chemotherapy: a meta-analysis
by: Dai P, et al.
Published: (2018-02-01)

S-1-based chemotherapy versus capecitabine-based chemotherapy as first-line treatment for advanced gastric carcinoma: a meta-analysis.
by: Ming-ming He, et al.
Published: (2013-01-01)

Addition of bevacizumab to first-line chemotherapy in advanced colorectal cancer: a systematic review and meta-analysis, with emphasis on chemotherapy subgroups
by: Macedo Ligia, et al.
Published: (2012-03-01)

Efficacy and safety of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma as first-line therapy
by: Myung Jin Oh, et al.
Published: (2013-09-01)

The Efficacy of Ginsenoside Rg3 Combined with First-line Chemotherapy in the Treatment of Advanced Non-Small Cell Lung Cancer in China: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
by: Ze Peng, et al.
Published: (2021-03-01)